DrugPatentWatch Database Preview
Amicus Theraps Us Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for AMICUS THERAPS US, and when can generic versions of AMICUS THERAPS US drugs launch?
AMICUS THERAPS US has one approved drug.
There are twelve US patents protecting AMICUS THERAPS US drugs.
There are ninety-seven patent family members on AMICUS THERAPS US drugs in twenty-six countries and sixteen supplementary protection certificates in fourteen countries.
Summary for Amicus Theraps Us
| International Patents: | 97 |
| US Patents: | 12 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Amicus Theraps Us
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amicus Theraps Us | GALAFOLD | migalastat hydrochloride | CAPSULE;ORAL | 208623-001 | Aug 10, 2018 | RX | Yes | Yes | 9,999,618 | Start Trial | Start Trial | ||||
| Amicus Theraps Us | GALAFOLD | migalastat hydrochloride | CAPSULE;ORAL | 208623-001 | Aug 10, 2018 | RX | Yes | Yes | 9,987,263 | Start Trial | Start Trial | ||||
| Amicus Theraps Us | GALAFOLD | migalastat hydrochloride | CAPSULE;ORAL | 208623-001 | Aug 10, 2018 | RX | Yes | Yes | 10,471,053 | Start Trial | Start Trial | ||||
| Amicus Theraps Us | GALAFOLD | migalastat hydrochloride | CAPSULE;ORAL | 208623-001 | Aug 10, 2018 | RX | Yes | Yes | 10,525,045 | Start Trial | Start Trial | ||||
| Amicus Theraps Us | GALAFOLD | migalastat hydrochloride | CAPSULE;ORAL | 208623-001 | Aug 10, 2018 | RX | Yes | Yes | 8,592,362 | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Amicus Theraps Us Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Denmark | 2946785 | Start Trial |
| Lithuania | C2787345 | Start Trial |
| Lithuania | PA2016033 | Start Trial |
| Hungary | E027569 | Start Trial |
| Slovenia | 2252313 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Amicus Theraps Us Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2787345 | 16C1014 | France | Start Trial | PRODUCT NAME: MIGALASTAT OU UN SEL DE CELUI-CI,NOTAMENT LE CHLORHYDRATE; REGISTRATION NO/DATE: EU1/15/1082 20160531 |
| 2787345 | 122016000090 | Germany | Start Trial | PRODUCT NAME: MIGALASTAT ODER EIN SALZ DAVON, EINSCHLIESSLICH DES HYDROCHLORIDSALZES; REGISTRATION NO/DATE: EU/1/15/1082/001 20160526 |
| 2787345 | 300843 | Netherlands | Start Trial | PRODUCT NAME: MIGALASTAT OF EEN ZOUT DAARVAN, WAARONDER HET HYDROCHLORIDEZOUT; REGISTRATION NO/DATE: EU/1/15/1082 20160531 |
| 2787345 | 268 5025-2016 | Slovakia | Start Trial | PRODUCT NAME: MIGALASTAT VO VSETKYCH FORMACH CHRANENYCH ZAKLADNYM PATENTOM; REGISTRATION NO/DATE: EU/1/15/1082 20160531 |
| 2787345 | CR 2016 00055 | Denmark | Start Trial | PRODUCT NAME: MIGALASTAT ELLER ET SALT HERAF, HERUNDER HYDROGENKLORIDSALTET; REG. NO/DATE: EU/1/15/1082 20160531 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
